Alzamend Neuro (ALZN) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Alzamend Neuro (ALZN) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | Alzamend Neuro | 5.54 Mn | 5.54 Mn | - | -0.86 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -0.86 |
| Jan 31, 2026 | -0.58 |
| Oct 31, 2025 | -0.30 |
| Jul 31, 2025 | -1.28 |
| Apr 30, 2025 | -3.64 |
| Jan 31, 2025 | -1.75 |
| Oct 31, 2024 | -3.61 |
| Jul 31, 2024 | -11.27 |
| Apr 30, 2024 | -11.33 |
| Jan 31, 2024 | -33.97 |
| Oct 31, 2023 | -39.85 |
| Jul 31, 2023 | -48.38 |
| Apr 30, 2023 | -45.76 |
| Jan 31, 2023 | -74.49 |
| Oct 31, 2022 | -43.07 |
| Jul 31, 2022 | -42.06 |
| Apr 30, 2022 | -58.69 |
| Jan 31, 2022 | -36.88 |
| Oct 31, 2021 | -52.00 |
| Jul 31, 2021 | -37.02 |